Striatal molecular mechanisms and motor dysfunction in Parkinson's disease
Identifieur interne : 000A93 ( PascalFrancis/Corpus ); précédent : 000A92; suivant : 000A94Striatal molecular mechanisms and motor dysfunction in Parkinson's disease
Auteurs : Thomas N. Chase ; Spiridon Konitsiotis ; Justin D. OhSource :
- Advances in neurology [ 0091-3952 ] ; 2001.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pR |
|
Format Inist (serveur)
NO : | PASCAL 03-0237960 INIST |
---|---|
ET : | Striatal molecular mechanisms and motor dysfunction in Parkinson's disease |
AU : | CHASE (Thomas N.); KONITSIOTIS (Spiridon); OH (Justin D.); CALNE (Donald); CALNE (Susan M.) |
AF : | Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health/Bethesda, Maryland 20892/Etats-Unis (1 aut., 2 aut., 3 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.) |
DT : | Publication en série; Congrès; Niveau analytique |
SO : | Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 355-360; Bibl. 67 ref. |
LA : | Anglais |
CC : | 002B17G |
FD : | Parkinson maladie; Physiopathologie; Homme; Corps strié |
FG : | Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Système nerveux pathologie |
ED : | Parkinson disease; Pathophysiology; Human; Corpus striatum |
EG : | Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases |
SD : | Parkinson enfermedad; Fisiopatología; Hombre; Cuerpo estriado |
LO : | INIST-15741.354000109446770360 |
ID : | 03-0237960 |
Links to Exploration step
Pascal:03-0237960Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Striatal molecular mechanisms and motor dysfunction in Parkinson's disease</title>
<author><name sortKey="Chase, Thomas N" sort="Chase, Thomas N" uniqKey="Chase T" first="Thomas N." last="Chase">Thomas N. Chase</name>
<affiliation><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Konitsiotis, Spiridon" sort="Konitsiotis, Spiridon" uniqKey="Konitsiotis S" first="Spiridon" last="Konitsiotis">Spiridon Konitsiotis</name>
<affiliation><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Oh, Justin D" sort="Oh, Justin D" uniqKey="Oh J" first="Justin D." last="Oh">Justin D. Oh</name>
<affiliation><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237960</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237960 INIST</idno>
<idno type="RBID">Pascal:03-0237960</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A93</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Striatal molecular mechanisms and motor dysfunction in Parkinson's disease</title>
<author><name sortKey="Chase, Thomas N" sort="Chase, Thomas N" uniqKey="Chase T" first="Thomas N." last="Chase">Thomas N. Chase</name>
<affiliation><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Konitsiotis, Spiridon" sort="Konitsiotis, Spiridon" uniqKey="Konitsiotis S" first="Spiridon" last="Konitsiotis">Spiridon Konitsiotis</name>
<affiliation><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Oh, Justin D" sort="Oh, Justin D" uniqKey="Oh J" first="Justin D." last="Oh">Justin D. Oh</name>
<affiliation><inist:fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Corpus striatum</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Pathophysiology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Physiopathologie</term>
<term>Homme</term>
<term>Corps strié</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0091-3952</s0>
</fA01>
<fA02 i1="01"><s0>ADNRA3</s0>
</fA02>
<fA03 i2="1"><s0>Adv. neurol.</s0>
</fA03>
<fA05><s2>86</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG"><s1>Striatal molecular mechanisms and motor dysfunction in Parkinson's disease</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>CHASE (Thomas N.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KONITSIOTIS (Spiridon)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>OH (Justin D.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland 20892</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1"><s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>355-360</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770360</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>67 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0237960</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Physiopathologie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Pathophysiology</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Fisiopatología</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Corps strié</s0>
<s5>21</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Corpus striatum</s0>
<s5>21</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Cuerpo estriado</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>146</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
<server><NO>PASCAL 03-0237960 INIST</NO>
<ET>Striatal molecular mechanisms and motor dysfunction in Parkinson's disease</ET>
<AU>CHASE (Thomas N.); KONITSIOTIS (Spiridon); OH (Justin D.); CALNE (Donald); CALNE (Susan M.)</AU>
<AF>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health/Bethesda, Maryland 20892/Etats-Unis (1 aut., 2 aut., 3 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 355-360; Bibl. 67 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Physiopathologie; Homme; Corps strié</FD>
<FG>Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Système nerveux pathologie</FG>
<ED>Parkinson disease; Pathophysiology; Human; Corpus striatum</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases</EG>
<SD>Parkinson enfermedad; Fisiopatología; Hombre; Cuerpo estriado</SD>
<LO>INIST-15741.354000109446770360</LO>
<ID>03-0237960</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000A93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:03-0237960 |texte= Striatal molecular mechanisms and motor dysfunction in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |